PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5650.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5650.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-40472.45%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-3050.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3050.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1209.23%
Share count expansion well above ACB.TO's 39.24%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1209.23%
Slight or no buyback while ACB.TO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-33934.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40083.77%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-51.16%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-51.16%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-51.16%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-117.44%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-117.44%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-117.44%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
74.46%
Positive growth while ACB.TO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
74.46%
Positive 5Y equity/share CAGR while ACB.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
74.46%
3Y equity/share CAGR above 1.5x ACB.TO's 6.93%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
110905.89%
Our AR growth while ACB.TO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
7369.40%
Asset growth above 1.5x ACB.TO's 93.77%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
552.07%
Positive BV/share change while ACB.TO is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41942.29%
We expand SG&A while ACB.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.